Human NK cell response to pathogens

Seminars in Immunology

Volumn 26, Issue 2, 2014, Pages 152-160

  Della Chiesa, Mariella ^a   Marcenaro, Emanuela ^a   Sivori, Simona ^a   Carlomagno, Simona ^a   Pesce, Silvia ^a   Moretta, Alessandro ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Anti viral response; BCG; HCMV; HIV; Natural killer cells; Toll like receptors

Indexed keywords

CD56 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 9;

CELL ACTIVATION; CELL EXPANSION; CELL MATURATION; CELL SUBPOPULATION; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN CYTOMEGALOVIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MYCOBACTERIUM BOVIS BCG; NATURAL KILLER CELL; REVIEW; CYTOMEGALOVIRUS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; KILLER CELLS, NATURAL; TOLL-LIKE RECEPTORS;

EID: 84897958374     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2014.02.001     Document Type: Review

References (138)

1. Marcenaro E., Carlomagno S., Pesce S., Moretta A., Sivori S. Bridging innate NK cell functions with adaptive immunity. Advances in Experimental Medicine and Biology 2011, 780:45-55.
2. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nature Immunology 2008, 9:503-510.
3. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nature Reviews Immunology 2002, 2:957-964.
4. Cerwenka A., Lanier L.L. Natural killer cells, viruses and cancer. Nature Reviews Immunology 2001, 1:41-49.
5. Bar E., Whitney P.G., Moor K., Reis E.S.C., Leibundgut-Landmann S. IL-17 regulates systemic fungal immunity by controlling the functional competence of NK cells. Immunity 2014, 40:117-127.
6. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nature Immunology 2004, 5:987-995.
7. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007, 449:819-826.
8. Lanier L.L. NK cell receptors. Annual Review of Immunology 1998, 16:359-393.
9. Long E.O. Regulation of immune responses through inhibitory receptors. Annual Review of Immunology 1999, 17:875-904.
10. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M.C., et al. Receptors for HLA class-I molecules in human natural killer cells. Annual Review of Immunology 1996, 14:619-648.
11. Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., Mingari M.C., et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annual Review of Immunology 2001, 19:197-223.
12. Long E.O., Kim H.S., Liu D., Peterson M.E., Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annual Review of Immunology 2013, 31:227-258.
13. Della Chiesa M., Sivori S., Castriconi R., Marcenaro E., Moretta A. Pathogen-induced private conversations between natural killer and dendritic cells. Trends in Microbiology 2005, 13:128-136.
14. Fadda L., Borhis G., Ahmed P., Cheent K., Pageon S.V., Cazaly A., et al. Peptide antagonism as a mechanism for NK cell activation. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:10160-10165.
15. Brunetta E., Hudspeth K.L., Mavilio D. Pathologic natural killer cell subset redistribution in HIV-1 infection: new insights in pathophysiology and clinical outcomes. Journal of Leukocyte Biology 2010, 88:1119-1130.
16. Alter G., Teigen N., Davis B.T., Addo M.M., Suscovich T.J., Waring M.T., et al. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 2005, 106:3366-3369.
17. Della Chiesa M., Falco M., Muccio L., Bertaina A., Locatelli F., Moretta A. Impact of HCMV infection on NK cell development and function after HSCT. Frontiers in Immunology 2013, 4:458.
18. Brunetta E., Fogli M., Varchetta S., Bozzo L., Hudspeth K.L., Marcenaro E., et al. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection. AIDS 2010, 24:27-34.
19. Carrington M., Alter G. Innate immune control of HIV. Cold Spring Harbor Perspectives in Medicine 2012, 2.
20. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
21. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunology 2010, 11:373-384.
22. Sabroe I., Jones E.C., Usher L.R., Whyte M.K.B., Dower S.K. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. Journal of Immunology 2002, 168:4701-4710.
23. Marone G., Genovese A., Granata F., Forte V., Detoraki A., de Paulis A., et al. Pharmacological modulation of human mast cells and basophils. Clinical and Experimental Allergy 2002, 32:1682-1689.
24. Bjerke T., Gaustadnes M., Nielsen S., Nielsen L.P., Schiotz P.O., Rudiger N., et al. Human blood eosinophils produce and secrete interleukin 4. Respiratory Medicine 1996, 90:271-277.
25. Jarrossay D., Napolitani G., Colonna M., Sallusto F., Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. European Journal of Immunology 2001, 31:3388-3393.
26. Supajatura V., Ushio H., Nakao A., Akira S., Okumura K., Ra C., et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. Journal of Clinical Investigation 2002, 109:1351-1359.
27. Parolini S., Santoro A., Marcenaro E., Luini W., Massardi L., Facchetti F., et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007, 109:3625-3632.
28. Becker I., Salaiza N., Aguirre M., Delgado J., Carrillo-Carrasco N., Kobeh L.G., et al. Leishmania lipophosphoglycan (LPG) activates NK cells through Toll-like receptor-2. Molecular and Biochemical Parasitology 2003, 130:65-74.
29. Marcenaro E., Ferranti B., Falco M., Moretta L., Moretta A. Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC. International Immunology 2008, 20:1155-1167.
30. Sivori S., Falco M., Della Chiesa M., Carlomagno S., Vitale M., Moretta L., et al. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:10116-10121.
31. Schmidt K.N., Leung B., Kwong M., Zarember K.A., Satyal S., Navas T.A., et al. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. Journal of Immunology 2004, 172:138-143.
32. Chalifour A., Jeannin P., Gauchat J.F., Blaecke A., Malissard M., N'Guyen T., et al. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production. Blood 2004, 104:1778-1783.
33. Hart O.M., Athie-Morales V., O'Connor G.M., Gardiner C.M. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. Journal of Immunology 2005, 175:1636-1642.
34. Alter G., Suscovich T.J., Teigen N., Meier A., Streeck H., Brander C., et al. Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells. Journal of Immunology 2007, 178:7658-7666.
35. Agaugue S., Marcenaro E., Ferranti B., Moretta L., Moretta A. Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells. Blood 2008, 112:1776-1783.
36. Morandi B., Bougras G., Muller W.A., Ferlazzo G., Munz C. NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion. European Journal of Immunology 2006, 36:2394-2400.
37. Marcenaro E., Della Chiesa M., Bellora F., Parolini S., Millo R., Moretta L., et al. IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors. Journal of Immunology 2005, 174:3992-3998.
38. Sivori S., Falco M., Carlomagno S., Romeo E., Moretta L., Moretta A. Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly(I:C) in human NK cells derived from different donors. International Immunology 2007, 19:1341-1348.
39. Sivori S., Vitale M., Morelli L., Sanseverino L., Augugliaro R., Bottino C., et al. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. Journal of Experimental Medicine 1997, 186:1129-1136.
40. Vitale M., Bottino C., Sivori S., Sanseverino L., Castriconi R., Marcenaro E., et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. Journal of Experimental Medicine 1998, 187:2065-2072.
41. Pende D., Parolini S., Pessino A., Sivori S., Augugliaro R., Morelli L., et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. Journal of Experimental Medicine 1999, 190:1505-1516.
42. Mavilio D., Benjamin J., Daucher M., Lombardo G., Kottilil S., Planta M.A., et al. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:15011-15016.
43. Costello R.T., Sivori S., Marcenaro E., Lafage-Pochitaloff M., Mozziconacci M.J., Reviron D., et al. Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 2002, 99:3661-3667.
44. Gerosa F., Gobbi A., Zorzi P., Burg S., Briere F., Carra G., et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. Journal of Immunology 2005, 174:727-734.
45. Sivori S., Carlomagno S., Moretta L., Moretta A. Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells. European Journal of Immunology 2006, 36:961-967.
46. Della Chiesa M., Romagnani C., Thiel A., Moretta L., Moretta A. Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses. Blood 2006, 108:3851-3858.
47. Esin S., Counoupas C., Aulicino A., Brancatisano F.L., Maisetta G., Bottai D., et al. Interaction of Mycobacterium tuberculosis cell wall components with the human natural killer cell receptors NKp44 and Toll-like receptor 2. Scandinavian Journal of Immunology 2013, 77:460-469.
48. Marcenaro E., Carlomagno S., Pesce S., Moretta A., Sivori S. NK/DC crosstalk in anti-viral response. Advances in Experimental Medicine and Biology 2012, 946:295-308.
49. Alexandroff A.B., Jackson A.M., O'Donnell M.A., James K. BCG immunotherapy of bladder cancer: 20 years on. Lancet 1999, 353:1689-1694.
50. Brandau S., Riemensberger J., Jacobsen M., Kemp D., Zhao W.C., Zhao X.Q., et al. NK cells are essential for effective BCG immunotherapy. International Journal of Cancer 2001, 92:697-702.
51. Brandau S., Bohle A. Activation of natural killer cells by bacillus Calmette-Guerin. European Urology 2001, 39:518-524.
52. Suttmann H., Jacobsen M., Reiss K., Jocham D., Bohle A., Brandau S. Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation. Journal of Urology 2004, 172:1490-1495.
53. Vankayalapati R., Garg A., Porgador A., Griffith D.E., Klucar P., Safi H., et al. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. Journal of Immunology 2005, 175:4611-4617.
54. Guerra C., Johal K., Morris D., Moreno S., Alvarado O., Gray D., et al. Control of Mycobacterium tuberculosis growth by activated natural killer cells. Clinical and Experimental Immunology 2012, 168:142-152.
55. Esin S., Batoni G., Pardini M., Favilli F., Bottai D., Maisetta G., et al. Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guerin. Immunology 2004, 112:143-152.
56. Batoni G., Esin S., Favilli F., Pardini M., Bottai D., Maisetta G., et al. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guerin. Scandinavian Journal of Immunology 2005, 62:498-506.
57. Portevin D., Young D. Natural killer cell cytokine response to M. bovis BCG is associated with inhibited proliferation, increased apoptosis and ultimate depletion of NKp44(+)CD56(bright) cells. PLoS ONE 2013, 8:e68864.
58. Esin S., Batoni G., Counoupas C., Stringaro A., Brancatisano F.L., Colone M., et al. Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria. Infection and Immunity 2008, 76:1719-1727.
59. Pende D., Biassoni R., Cantoni C., Verdiani S., Falco M., di Donato C., et al. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. Journal of Experimental Medicine 1996, 184:505-518.
60. Sivori S., Falco M., Carlomagno S., Romeo E., Soldani C., Bensussan A., et al. A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2. Blood 2010, 116:1637-1647.
61. Sivori S., Falco M., Moretta L., Moretta A. Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products. Trends in Immunology 2010, 31:289-294.
62. Hansasuta P., Dong T., Thananchai H., Weekes M., Willberg C., Aldemir H., et al. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. European Journal of Immunology 2004, 34:1673-1679.
63. Wilson M.J., Torkar M., Haude A., Milne S., Jones T., Sheer D., et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:4778-4783.
64. Muntasell A., Costa-Garcia M., Vera A., Marina-Garcia N., Kirschning C.J., Lopez-Botet M. Priming of NK cell anti-viral effector mechanisms by direct recognition of human cytomegalovirus. Frontiers in Immunology 2013, 4:40.
65. Diebold S.S., Kaisho T., Hemmi H., Akira S., Sousa C.R.E. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
66. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
67. Beignon A.S., McKenna K., Skoberne M., Manches O., DaSilva I., Kavanagh D.G., et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via toll-like receptor-viral RNA interactions. Journal of Clinical Investigation 2005, 115:3265-3275.
68. Martinelli E., Cicala C., Van Ryk D., Goode D.J., Macleod K., Arthos J., et al. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-alpha secretion in plasmacytoid dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:3396-3401.
69. Stacey A.R., Norris P.J., Qin L., Haygreen E.A., Taylor E., Heitman J., et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. Journal of Virology 2009, 83:3719-3733.
70. Boehme K.W., Guerrero M., Compton T. Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. Journal of Immunology 2006, 177:7094-7102.
71. Krug A., French A.R., Barchet W., Fischer J.A., Dzionek A., Pingel J.T., et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004, 21:107-119.
72. Tabeta K., Georgel P., Janssen E., Du X., Hoebe K., Crozat K., et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:3516-3521.
73. Szomolanyi-Tsuda E., Liang X., Welsh R.M., Kurt-Jones E.A., Finberg R.W. Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. Journal of Virology 2006, 80:4286-4291.
74. Zucchini N., Bessou G., Traub S., Robbins S.H., Uematsu S., Akira S., et al. Cutting edge: overlapping functions of TLR7 and TLR9 for innate defense against a herpesvirus infection. Journal of Immunology 2008, 180:5799-5803.
75. Carvalho A., Cunha C., Carotti A., Aloisi T., Guarrera O., Di Ianni M., et al. Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation. Experimental Hematology 2009, 37:1022-1029.
76. Alter G., Altfeld M. NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection. Journal of Internal Medicine 2009, 265:29-42.
77. Marcenaro E., Carlomagno S., Pesce S., Della Chiesa M., Parolini S., Moretta A., et al. NK cells and their receptors during viral infections. Immunotherapy 2011, 3:1075-1086.
78. Cohen G.B., Gandhi R.T., Davis D.M., Mandelboim O., Chen B.K., Strominger J.L., et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999, 10:661-671.
79. Le Gall S., Erdtmann L., Benichou S., Berlioz-Torrent C., Liu L., Benarous R., et al. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 1998, 8:483-495.
80. Zingoni A., Ardolino M., Santoni A., Cerboni C. NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses. Frontiers in Immunology 2012, 3:408.
81. Martin M.P., Gao X., Lee J.H., Nelson G.W., Detels R., Goedert J.J., et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nature Genetics 2002, 31:429-434.
82. Martin M.P., Qi Y., Gao X., Yamada E., Martin J.N., Pereyra F., et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nature Genetics 2007, 39:733-740.
83. Jennes W., Verheyden S., Demanet C., Adje-Toure C.A., Vuylsteke B., Nkengasong J.N., et al. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. Journal of Immunology 2006, 177:6588-6592.
84. Alter G., Martin M.P., Teigen N., Carr W.H., Suscovich T.J., Schneidewind A., et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. Journal of Experimental Medicine 2007, 204:3027-3036.
85. Correa I., Raulet D.H. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 1995, 2:61-71.
86. Malnati M.S., Peruzzi M., Parker K.C., Biddison W.E., Ciccone E., Moretta A., et al. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 1995, 267:1016-1018.
87. Peruzzi M., Parker K.C., Long E.O., Malnati M.S. Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. Journal of Immunology 1996, 157:3350-3356.
88. Rajagopalan S., Long E.O. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. Journal of Experimental Medicine 1997, 185:1523-1528.
89. Zappacosta F., Borrego F., Brooks A.G., Parker K.C., Coligan J.E. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:6313-6318.
90. Cooper M.A., Fehniger T.A., Caligiuri M.A. The biology of human natural killer-cell subsets. Trends in Immunology 2001, 22:633-640.
91. Fauriat C., Long E.O., Ljunggren H.G., Bryceson Y.T. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 2010, 115:2167-2176.
92. Marcenaro E., Pesce S., Sivori S., Carlomagno S., Moretta L., Moretta A. KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts. Blood 2013, 121:3396-3401.
93. De Maria A., Bozzano F., Cantoni C., Moretta L. Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:728-732.
94. Mavilio D., Lombardo G., Benjamin J., Kim D., Follman D., Marcenaro E., et al. Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:2886-2891.
95. Gonzalez V.D., Falconer K., Michaelsson J., Moll M., Reichard O., Alaeus A., et al. Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin. Clinical Immunology 2008, 128:46-56.
96. Wilk E., Kalippke K., Buyny S., Schmidt R.E., Jacobs R. New aspects of NK cell subset identification and inference of NK cells' regulatory capacity by assessing functional and genomic profiles. Immunobiology 2008, 213:271-283.
97. De Maria A., Fogli M., Costa P., Murdaca G., Puppo F., Mavilio D., et al. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). European Journal of Immunology 2003, 33:2410-2418.
98. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. Journal of Experimental Medicine 2002, 195:327-333.
99. Mavilio D., Lombardo G., Kinter A., Fogli M., La Sala A., Ortolano S., et al. Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. Journal of Experimental Medicine 2006, 203:2339-2350.
100. Marcenaro E., Ferranti B., Moretta A. NK-DC interaction: on the usefulness of auto-aggression. Autoimmunity Reviews 2005, 4:520-525.
101. Fogli M., Mavilio D., Brunetta E., Varchetta S., Ata K., Roby G., et al. Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. PLoS Pathogens 2008, 4:e1000101.
102. Brunetta E., Fogli M., Varchetta S., Bozzo L., Hudspeth K.L., Marcenaro E., et al. The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. Blood 2009, 114:3822-3830.
103. Guma M., Budt M., Saez A., Brckalo T., Hengel H., Angulo A., et al. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006, 107:3624-3631.
104. Guma M., Cabrera C., Erkizia I., Bofill M., Clotet B., Ruiz L., et al. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. Journal of Infectious Diseases 2006, 194:38-41.
105. Dowd J.B., Aiello A.E., Alley D.E. Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiology and Infection 2009, 137:58-65.
106. Ho M. Epidemiology of cytomegalovirus infections. Reviews of Infectious Diseases 1990, 12(Suppl. 7):S701-S710.
107. La Rosa C., Diamond D.J. The immune response to human CMV. Future Virology 2012, 7:279-293.
108. Guma M., Angulo A., Vilches C., Gomez-Lozano N., Malats N., Lopez-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004, 104:3664-3671.
109. Beziat V., Liu L.L., Malmberg J.A., Ivarsson M.A., Sohlberg E., Bjorklund A.T., et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 2013, 121:2678-2688.
110. Petitdemange C., Becquart P., Wauquier N., Beziat V., Debre P., Leroy E.M., et al. Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathogens 2011, 7:e1002268.
111. Bjorkstrom N.K., Lindgren T., Stoltz M., Fauriat C., Braun M., Evander M., et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. Journal of Experimental Medicine 2011, 208:13-21.
112. Beziat V., Dalgard O., Asselah T., Halfon P., Bedossa P., Boudifa A., et al. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. European Journal of Immunology 2012, 42:447-457.
113. Saghafian-Hedengren S., Sohlberg E., Theorell J., Carvalho-Queiroz C., Nagy N., Persson J.O., et al. Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells. Journal of Virology 2013, 87:13446-13455.
114. Tortorella D., Gewurz B.E., Furman M.H., Schust D.J., Ploegh H.L. Viral subversion of the immune system. Annual Review of Immunology 2000, 18:861-926.
115. Kaiser B.K., Pizarro J.C., Kerns J., Strong R.K. Structural basis for NKG2A/CD94 recognition of HLA-E. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:6696-6701.
116. Prod'homme V., Griffin C., Aicheler R.J., Wang E.C., McSharry B.P., Rickards C.R., et al. The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells. Journal of Immunology 2007, 178:4473-4481.
117. Heatley S.L., Pietra G., Lin J., Widjaja J.M., Harpur C.M., Lester S., et al. Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells. Journal of Biological Chemistry 2013, 288:8679-8690.
118. Magri G., Muntasell A., Romo N., Saez-Borderias A., Pende D., Geraghty D.E., et al. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 2011, 117:848-856.
119. Djaoud Z., David G., Bressollette C., Willem C., Rettman P., Gagne K., et al. Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: functional impact in controlling CMV-infected dendritic cells. Journal of Immunology 2013, 191:2708-2716.
120. Kuijpers T.W., Baars P.A., Dantin C., van den Burg M., van Lier R.A., Roosnek E. Human NK cells can control CMV infection in the absence of T cells. Blood 2008, 112:914-915.
121. Farnault L., Chambost H., Michel G., Thuret I., de Saint Basile G., Fischer A., et al. Persistence of natural killer cells with expansion of a hypofunctional CD56-CD16+KIR+NKG2C+ subset in a patient with atypical Janus kinase 3-deficient severe combined immunodeficiency. Journal of Allergy and Clinical Immunology 2013, 131:1230-1233. 1230-3, 1233 e1231-2.
122. Della Chiesa M., Falco M., Podesta M., Locatelli F., Moretta L., Frassoni F., et al. Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?. Blood 2012, 119:399-410.
123. Foley B., Cooley S., Verneris M.R., Pitt M., Curtsinger J., Luo X., et al. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 2011, 119:2665-2674.
124. Lopez-Verges S., Milush J.M., Pandey S., York V.A., Arakawa-Hoyt J., Pircher H., et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 2010, 116:3865-3874.
125. Bjorkstrom N.K., Riese P., Heuts F., Andersson S., Fauriat C., Ivarsson M.A., et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010, 116:3853-3864.
126. Wu Z., Sinzger C., Frascaroli G., Reichel J., Bayer C., Wang L., et al. Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity. Journal of Virology 2013, 87:7717-7725.
127. Lopez-Verges S., Milush J.M., Schwartz B.S., Pando M.J., Jarjoura J., York V.A., et al. Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:14725-14732.
128. Sun J.C., Lopez-Verges S., Kim C.C., DeRisi J.L., Lanier L.L. NK cells and immune "memory". Journal of Immunology 2011, 186:1891-1897.
129. Foley B., Cooley S., Verneris M.R., Curtsinger J., Luo X., Waller E.K., et al. Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen. Journal of Immunology 2012, 189:5082-5088.
130. Romee R., Schneider S.E., Leong J.W., Chase J.M., Keppel C.R., Sullivan R.P., et al. Cytokine activation induces human memory-like NK cells. Blood 2012, 120:4751-4760.
131. Cooper M.A., Colonna M., Yokoyama W.M. Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Reports 2009, 10:1103-1110.
132. Stern M., Elsasser H., Honger G., Steiger J., Schaub S., Hess C. The number of activating KIR genes inversely correlates with the rate of CMV infection/reactivation in kidney transplant recipients. American Journal of Transplantation 2008, 8:1312-1317.
133. Stern M., Hadaya K., Honger G., Martin P.Y., Steiger J., Hess C., et al. Telomeric rather than centromeric activating KIR genes protect from cytomegalovirus infection after kidney transplantation. American Journal of Transplantation 2011, 11:1302-1307.
134. Cook M., Briggs D., Craddock C., Mahendra P., Milligan D., Fegan C., Donor K.I.R., et al. genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation. Blood 2006, 107:1230-1232.
135. Elmaagacli A.H., Steckel N.K., Koldehoff M., Hegerfeldt Y., Trenschel R., Ditschkowski M., et al. Early human cytomegalovirus replication after transplant is associated with a decreased relapse-risk: evidence for a putative virus-versus-leukemia effect AML patients. Blood 2011, 118:1402-1412.
136. Manjappa S., Bhamidipati P.K., Stokerl-Goldstein K.E., Dipersio J.F., Uy G.L., Westervelt P., et al. Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen. Biology of Blood and Marrow Transplantation 2014, 20:46-52.
137. Ruggeri L., Aversa F., Martelli M.F., Velardi A. Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. Immunological Reviews 2006, 214:202-218.
138. -/- umbilical cord blood. Journal of Immunology 2014, 192:1471-1479.